Announcements Trials
Browse Landscape

Phase

Phase NA 41Phase 3 5Phase 2 3Phase 2/3 1

Status

Terminated 3Recruiting 3Not yet recruiting 2Completed 2Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 2Breast 2

Conditions

Prostatic Neoplasms 2Breast Neoplasms 1Anatomic Stage I Breast Cancer American Joint Committee on Cancer (AJCC) v8 1

Interventions

pembrolizumab 223Carboplatin 222Specimen Handling 194Cisplatin 192Magnetic Resonance Spectroscopy 165Radiotherapy 153Bevacizumab 143Gemcitabine 136Cyclophosphamide 135Drug Therapy 119Capecitabine 118Paclitaxel 116Oxaliplatin 111Nivolumab 105Biopsy 104venetoclax 103tislelizumab 83Rituximab 83durvalumab 82toripalimab 78Fluorouracil 73Etoposide 72Docetaxel 69Dexamethasone 69sintilimab 67Pemetrexed 67atezolizumab 65Radiosurgery 65Azacitidine 63130-nm albumin-bound paclitaxel 62

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × Recruiting × Methods × Clear all
NCT06113016 2025-07-08

PROFFi

Jonsson Comprehensive Cancer Center

Phase 2 Recruiting
164 enrolled
Breast

Anatomic Stage I Breast Cancer American Joint Committee on Cancer (AJCC) v8

NCT06049355 2025-05-29

EMBRACE: Exercising Together

OHSU Knight Cancer Institute

Phase 2 Recruiting
400 enrolled
BreastGenitourinary

Breast Neoplasms, Prostatic Neoplasms

NCT05054296 2023-03-29

Modifying Metabolic Syndrome and Cardiovascular Risk for Prostate Cancer Patients on ADT Using a Risk Factor Modification Program and Continuous Fitbit Monitoring

M.D. Anderson Cancer Center

Phase 2 Recruiting
200 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡